| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Health Foundation,3 Valhalla, New York 10595
2 To whom requests for reprints should be addressed, at American Health Foundation, 1 Dana Road, Valhalla, NY 10595.
Two diol-epoxide metabolites of benzo[c]phenanthrene and benzo[a]pyrene, polynuclear aromatic hydrocarbons which occur in the environment, were tested for carcinogenicity by direct injection into the mammary fat pads of female CD rats. The compounds anti-3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene (BcPDE), a fjord region diol-epoxide, and anti-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene, a bay region diol-epoxide, were applied at total doses of 12.2 µmol. 6-Nitrochrysene was applied at the same dose as a positive control (K. El-Bayoumy, A. Rivenson, P. Upadhyaya, Y-H. Chae, and S. S. Hecht, Cancer Res. 53: 3719–3722, 1993). The sterically hindered fjord region diol-epoxide BcPDE was a powerful mammary tumorigen and carcinogen, rapidly inducing significantly more fibroadenoma and adenocarcinoma than either of the other compounds. Anti-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene was a weaker mammary tumorigen than BcPDE and 6-nitrochrysene. The results of this study provide the first evidence for mammary tumorigenicity of polynuclear aromatic hydrocarbon diol-epoxides and demonstrate the potent mammary carcinogenicity of BcPDE.
1 This study was supported by Grants CA-44377 and CA-35519 from the National Cancer Institute. This is Paper 152 in "A Study of Chemical Carcinogenesis."
3 Contributing facilities are supported in part by Cancer Center Support Grant CA-17613 from the National Cancer Institute.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 9/16/93. Accepted 11/16/93.
This article has been cited by other articles:
![]() |
V. K. Batra, D. D. Shock, R. Prasad, W. A. Beard, E. W. Hou, L. C. Pedersen, J. M. Sayer, H. Yagi, S. Kumar, D. M. Jerina, et al. Structure of DNA polymerase beta with a benzo[c]phenanthrene diol epoxide-adducted template exhibits mutagenic features PNAS, November 14, 2006; 103(46): 17231 - 17236. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wu, S. Yan, D. J. Patel, N. E. Geacintov, and S. Broyde Relating repair susceptibility of carcinogen-damaged DNA with structural distortion and thermodynamic stability Nucleic Acids Res., August 1, 2002; 30(15): 3422 - 3432. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimada, K. Inoue, Y. Suzuki, T. Kawai, E. Azuma, T. Nakajima, M. Shindo, K. Kurose, A. Sugie, Y. Yamagishi, et al. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice Carcinogenesis, July 1, 2002; 23(7): 1199 - 1207. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jyonouchi, S. Sun, V. A. Porter, and D. N. Cornfield Polycyclic Aromatic Hydrocarbon Diol Epoxides Increase Cytosolic Ca2+ of Airway Epithelial Cells Am. J. Respir. Cell Mol. Biol., July 1, 2001; 25(1): 78 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Buterin, M. T. Hess, N. Luneva, N. E. Geacintov, S. Amin, H. Kroth, A. Seidel, and H. Naegeli Unrepaired Fjord Region Polycyclic Aromatic Hydrocarbon-DNA Adducts in ras Codon 61 Mutational Hot Spots Cancer Res., April 1, 2000; 60(7): 1849 - 1856. [Abstract] [Full Text] |
||||
![]() |
A. Pal, A. Seidel, H. Xia, X. Hu, S. K. Srivastava, F. Oesch, and S. V. Singh Specificity of murine glutathione S- transferase isozymes in the glutathione conjugation of (–)- anti- and (+)-syn-stereoisomers of benzo[g]chrysene 11,12-diol 13,14-epoxide Carcinogenesis, October 1, 1999; 20(10): 1997 - 2001. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Shimada, E. M. J. Gillam, T. R. Sutter, P. T. Strickland, F. P. Guengerich, and H. Yamazaki Oxidation of Xenobiotics by Recombinant Human Cytochrome P450 1B1 Drug Metab. Dispos., May 1, 1997; 25(5): 617 - 622. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |